RET and colon adenocarcinoma: Of note, 41.7% (25/60) of the RET fusion-positive colon adenocarcinomas had an MSI-H status which was significantly higher than the RET fusion negative colon adenocarcinoma (5.5%, 1805/32,938) (p < 0.001) (Supplementary Table 4).